CIK 0001628908
- Large accelerated filer
Evolent Health, Inc.
Sign in to watch- Ticker
- EVH
- Exchange
- NYSE
- Industry
- Services-Management Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320454912
- Phone
- +1 571-389-6000
- Business address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
- 4 Open-market sale President sold 85,596 shares at an average $17.08 ($1,462,374)
- 4 Open-market sale Director sold 3,040,000 shares at $13.70 ($41,648,000)
- 4 Grant or award Chief Accounting Officer acquired 7,168 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 25,090 shares (grant or award)
- 4 Grant or award General Counsel acquired 10,753 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 22,401 shares (grant or award)
- 4 Grant or award President acquired 86,022 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 96,774 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 6,684 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 16,300 shares at $23.73 ($386,799)
- 4 Open-market sale CEO, Valence Health sold 6,000 shares at $24.64 ($147,840)
- 4 Open-market sale Chief Operating Officer sold 40,540 shares at $26.00 ($1,054,040)
- 4 Open-market sale Chief Financial Officer sold 1,667 shares at $25.42 ($42,375)
- 4 Open-market sale Chief Executive Officer sold 16,300 shares at an average $24.76 ($403,624)
- 4 Open-market sale CEO, Valence Health sold 6,000 shares at $25.07 ($150,420)
- 4 Open-market sale 10% owner sold 4,279,325 shares at $25.87 ($110,706,138)
- 4 Open-market sale President sold 15,000 shares at $25.22 ($378,300)
- 4 Open-market sale Chief Financial Officer sold 1,667 shares at an average $24.58 ($40,979)
Page 15 of 22 · 421 filings